Health Products Research Reports on 2004 Promotional Activities to ...

... Health Products Research Reports on 2004 Promotional Activities to Hematology and Oncology Specialists Health Products Research Reports on 2004 Promotional Activities to Hematology and Oncology Specialists * Aranesp(R) Gives Amgen Greatest Share of Voice Among Hematologists and Oncologists * Pharmaceutical Sales Force Promotion to Hematology and Oncology Specialists Increased 4% in 2004 * Aranesp(R) (Amgen), Taxotere(R) (Sanofi Aventis) and Procrit(R) (Ortho Biotech) Ranked as Top 3 Products with Hematologists and Oncologists in 2004 * 6 Products Enter Top 20 Ranking for the First Time WHITEHOUSE, N.J., April 7 /PRNewswire-FirstCall/ - Health Products Research, Inc.(R) (HPR(R)), a division of Ventiv Health, Inc.

(Nasdaq: VTIV), released 2004 market information on pharmaceutical sales force promotional activities to Hematology and Oncology specialists across the United States.

HPR generates market data from its Metropolitan Area Promotional Audit (MPA), a monthly service that provides quantitative and qualitative insights and real-time data from pharmaceutical/healthcare company promotional activities and sales force structure.

Key findings from the 2004 Hematology and Oncology specialists MPA report include: * Nationwide, pharmaceutical sales force promotion to Hematology and Oncology specialists increased 4% in 2004 compared to the prior year, bolstered by sales force promotion behind six products entering the top 20 in 2004, as well as increased prom...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news